Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NiKang Therapeutics
AddedFeb 13, 2024
UpdatedJun 18, 2026
NiKang Therapeutics

NiKang Therapeutics

Series C

NiKang Therapeutics: Pioneering in small molecule oncology drug discovery and development for cancer cure.

HQ
Wilmington, DE, US
Founded
2017
Overview
Compare
Fundraising
Employees

NiKang Therapeutics, Inc. is a biotech company dedicated to developing novel small molecule oncology drugs. Their mission is to create first-in-class and best-in-class targeted therapies and immuno-oncology drugs to combat cancer. They focus on innovative drug discovery to provide effective treatments for cancer patients.

NiKang Therapeutics has made significant strides in oncology drug development, contributing to the advancement of cancer treatment. Their pioneering approach in small molecule therapies has positioned them as a key player in the biotech industry, driving impactful progress in cancer research and treatment.

NiKang Therapeutics - Similar Companies

Niiki Pharma logo

Niiki Pharma

Nirogy Therapeutics logo

Nirogy Therapeutics

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Traws Pharma logo

Traws Pharma

Nexo Therapeutics logo

Nexo Therapeutics

nexotx.com

Xios Therapeutics logo

Xios Therapeutics

NKT Therapeutics logo

NKT Therapeutics

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Onkaido Therapeutics logo

Onkaido Therapeutics

ImageneBio logo

ImageneBio

ikenaoncology.com

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Curelab Oncology logo

Curelab Oncology

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

NextCure logo

NextCure

nextcure.com

Akanocure Pharmaceuticals logo

Akanocure Pharmaceuticals

akanocure.com

NiKang Therapeutics - Quick Facts

Who are NiKang Therapeutics' competitors?

Companies similar to NiKang Therapeutics include Niiki Pharma, Nirogy Therapeutics, Synnovation Therapeutics and Traws Pharma.

When was NiKang Therapeutics founded?

NiKang Therapeutics was founded in 2017.

Where is NiKang Therapeutics' headquarters located?

NiKang Therapeutics' headquarters is located in Wilmington, DE, US.

When was NiKang Therapeutics' last funding round?

NiKang Therapeutics' most recent funding round was for $200M (USD) in May 2021.

How much has NiKang Therapeutics raised to-date?

As of May 26, 2021, NiKang Therapeutics has raised a total of $260M (USD).

How many employees does NiKang Therapeutics have?

NiKang Therapeutics has 36 employees as of Feb 5, 2024.

NiKang Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Drugs
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified